INVE
Identiv, Inc.
INVE has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over INVE overall, supported by stronger fundamentals and stronger modeled upside.
INVE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Strong |
INVE's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
INVE PE Valuation
INVE has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
INVE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect INVE's losses to shrink, with revenue growing.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
INVE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.67 | -121% |
| Q1 2026 | -$0.73 | -123% |
| Q4 2025 | -$0.79 | -125% |
| Q3 2025 | -$0.62 | -120% |
| Q2 2025 | $3.15 | +$3.73 |
| Q1 2025 | $3.14 | +$3.51 |
| Q4 2024 | $3.14 | +$3.43 |
| Q3 2024 | $3.05 | +$3.25 |
INVE has swung to a loss: it lost $0.67 per share over the past year, after a profit the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over INVE in the latest year-over-year earnings comparison.
INVE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.7M | +13% |
| Q1 2026 | $7.4M | +41% |
| Q4 2025 | $6.2M | -7.9% |
| Q3 2025 | $5M | -23% |
| Q2 2025 | $5M | -25% |
| Q1 2025 | $5.3M | -77% |
| Q4 2024 | $6.7M | -77% |
| Q3 2024 | $6.5M | -79% |
INVE's revenue is recovering but still below its 2023 peak: $6M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -97% | +30 points |
| Q1 2026 | -57% | +47 points |
| Q4 2025 | -76% | +23 points |
| Q3 2025 | -111% | +35 points |
| Q2 2025 | -127% | -27 points |
| Q1 2025 | -104% | -85 points |
| Q4 2024 | -99% | -93 points |
| Q3 2024 | -146% | -147 points |
INVE's operating margin was −97% last quarter, up 30 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over INVE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over INVE on profitability, with a higher operating margin.
INVE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.1M | -$1.2M |
| Q1 2026 | -$3.7M | -$136K |
| Q4 2025 | $2.8M | +$9.4M |
| Q3 2025 | -$3.2M | +$4.5M |
| Q2 2025 | -$3.8M | -$2.7M |
| Q1 2025 | -$3.6M | -$2M |
| Q4 2024 | -$6.5M | -280% |
| Q3 2024 | -$7.7M | -$6.7M |
INVE has burned cash in most quarters: −$9M over the past year, against −$22M the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over INVE on cash generation, producing positive trailing cash flow while its opponent burns cash.
INVE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | -31.8x | Net Cash |
| Q4 2022 | -8.6x | Net Cash |
| Q2 2022 | -25.1x | Net Cash |
| Q1 2022 | -31.8x | Net Cash |
| Q2 2021 | -15.2x | Net Cash |
| Q1 2021 | 97.4x | High |
| Q1 2020 | 13.1x | High |
| Q4 2019 | 1.4x | Healthy |
INVE has more cash than debt.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
INVE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.9 | Neutral |
| Stochastic | 58.4 | Neutral |
INVE's weekly RSI is 46 (neutral) and its Stochastic is 58 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
INVE PE vs Technology Sector
| Metric | INVE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INVE has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
INVE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.53 | 5.5% above |
| 20 week MA | $2.63 | 1.5% above |
| 50 week MA | $3.24 | 18% below |
| 100 week MA | $3.36 | 21% below |
| 200 week MA | $4.79 | 44% below |
INVE has stronger trend alignment. INVE is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
INVE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.60 | $7.24 | +29% |
| 2021 | $7.24 | $24.4 | +237% |
| 2022 | $24.4 | $6.87 | -72% |
| 2023 | $6.87 | $8.24 | +20% |
| 2024 | $8.24 | $3.69 | -55% |
| 2025 | $3.69 | $3.43 | -7% |
| 2026 YTD | $3.43 | $2.67 | -22% |
INVE's yearly returns have swung widely, from +237% in 2021 to −72% in 2022. It's down 22% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over INVE on returns for 2026, with the stronger performance.